doi: 10.3389/fmed.2021.689042 Received 31 March 2021 Accepted 15 June 2021 Published 09 August 2021 Volume 8 - 2021 Edited by Oscar Escribano, Complutense University of Madrid, Spain Reviewed by Adriaan Holleboom, Academic Medical Center, Netherlands
However, as discussed later in the CY 2026 OPPS/ASC proposed rule (90 FR 33775 and 33776), we also proposed that the Emergency Care Access & Timeliness eCQM would not be a required measure under the REHQR Program, and that REHs could thus elect to report either the Emergency Care Access & Timeliness eCQM or the Median Time for Discharged ED Patients measure for a given reporting period/program determination
For within-group analyses, statistical significance was tested with a paired Students t -test or one-way ANOVA followed by Tukeys post hoc analysis for multiple comparisons
The version without DAC, commonly called Mod GRF 1-29 (Modified Growth Hormone Releasing Factor, amino acids 1-29), has a half-life of about 30 minutes and requires daily or twice-daily injections
